Takeda’s Actoplus Met For Type 2 Diabetes Will Launch In October
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves the single-pill combination of Takeda’s Actos (pioglitazone) and metformin.
You may also be interested in...
Thelin Gets EMEA Committee Approval Recommendation
The European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization approval of Encysive's pulmonary arterial hypertension therapy Thelin (sitaxsentan), the agency announced June 2
Thelin Gets EMEA Committee Approval Recommendation
The European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization approval of Encysive's pulmonary arterial hypertension therapy Thelin (sitaxsentan), the agency announced June 2
Paxil CR In Recovery, But Still Hobbling GSK’s U.S. Rx Sales Growth
Controlled-release paroxetine recaptures 41% of pre-seizure new prescription share, but the sales interruption still slows growth of GSK’s U.S. pharma business during the second quarter.